CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹184 Cr | ₹142 Cr | ₹192 Cr | ₹344 Cr | ₹236 Cr |
What is the latest Total Current Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹184 Cr |
| Mar2024 | ₹142 Cr |
| Mar2023 | ₹192 Cr |
| Mar2022 | ₹344 Cr |
| Mar2021 | ₹236 Cr |
How is Total Current Liabilities of CONCORD BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹184 Cr | 29.48 | |
| Mar2024 | ₹142 Cr | -25.90 | |
| Mar2023 | ₹192 Cr | -44.27 | |
| Mar2022 | ₹344 Cr | 45.91 | |
| Mar2021 | ₹236 Cr | - | |
Compare Total Current Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹10,731.4 Cr | -1.7% | -18.2% | -39.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -1.7% |
-18.2% |
-39.9% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses